Bowen disease of the eyelid successfully treated with imiquimod

Ophthalmic Plastic and Reconstructive Surgery

Volumn 21, Issue 4, 2005, Pages 321-322

  Brannan, Paul A ^a,b   Anderson, Heidi K ^a   Kersten, Robert C ^a   Kulwin, Dwight R ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IMIQUIMOD; STEROID;

AGED; ARTICLE; BOWEN DISEASE; CANCER CHEMOTHERAPY; CASE REPORT; CREAM; CRYOTHERAPY; ECTROPION; EYELID CANCER; GERIATRIC PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOWER EYELID; MALE; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AGED; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; BOWEN'S DISEASE; EYELID NEOPLASMS; HUMANS; MALE; OINTMENTS; SKIN NEOPLASMS;

EID: 23244449225     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iop.0000170421.07098.61     Document Type: Article

References (6)

1. Arlette J, Trotter M. Squamous cell carcinoma in situ of the skin: History, presentation, biology and treatment. Australasian J Dermatol 2004;45:1-11.
2. Mackenzie-Wood A, Kossard S, de Launey, J, et al. Imiquimod 5% cream in the treatment of Bowen's disease. J Am Acad Dermatol 2001;44:462-70.
3. Salasche S, Shumack S. A review of imiquimod 5% cream for the treatment of various dermatological conditions. Clin Exp Dermatol 2003;28:1-3.
4. Schön M, Bong AB, Drewniok C, et al. Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Nat Cancer Inst 2003;95(15):1138-49.
5. Kossard S. Treatment of large facial Bowen's disease: case report. Clin Exp Dermatol 2003;28:13-15.
6. Hengge U, Stark R. Topical imiquimod to treat intraepidermal carcinoma. Arch Dermatol 2001;137:709-11.